What is BTS Research?
Headquartered in San Diego, BTS Research operates as a premier Contract Research Organization (CRO) that has been instrumental in advancing preclinical science since 2001. The company provides a comprehensive suite of in vitro and in vivo biological services, catering to a diverse clientele that spans pharmaceutical giants, emerging biotech firms, medical device manufacturers, and academic institutions. By offering deep expertise in toxicology, pharmacology, and the complex Investigational New Drug (IND) submission process, BTS Research serves as a vital bridge between early-stage discovery and clinical trials. Their infrastructure, which includes sophisticated laboratory environments and specialized vivarium facilities, ensures that clients receive high-quality, regulatory-compliant data necessary for navigating the rigorous demands of modern drug development.
How much funding has BTS Research raised?
BTS Research has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in BTS Research
PPP
Public-Private Partnership
What's next for BTS Research?
The influx of capital positions BTS Research to scale its service offerings and potentially expand its state-of-the-art laboratory capacity. As the pharmaceutical industry faces increasing pressure to accelerate time-to-market for novel therapeutics, the demand for high-fidelity preclinical data is at an all-time high. BTS Research is well-positioned to leverage this strategic backing to enhance its custom service models and disease-specific research capabilities. By maintaining its focus on regulatory excellence and scientific precision, the firm is poised to capture a larger share of the outsourced research market, further cementing its reputation as a trusted partner in the global life sciences ecosystem.
See full BTS Research company page
